OTC Pharmaceuticals - Northern Africa

Northern Africa

The OTC Pharmaceuticals market in Northern Africa is projected to generate a revenue of US$3,021.00m in 2024.
It is expected to experience an annual growth rate of 7.64% (CAGR 2024-2029).
Among the various markets, the largest one is Vitamins & Minerals, which is estimated to reach a market volume of US$765.30m in 2024.
When compared globally, the in the United States leads in terms of revenue generation, with an estimated revenue of US$41,240.00m in 2024.
In relation to the total population figures, the per person revenue in Northern Africa is expected to be US$11.58 in 2024.
Furthermore, online sales are projected to contribute 5.81% of the total revenue in the OTC Pharmaceuticals market by 2024.
The demand for OTC pharmaceuticals in Northern Africa is rising due to an increasing awareness of self-medication and access to healthcare.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Northern Africa is experiencing significant growth and development due to several factors. Customer preferences for self-medication, increasing healthcare awareness, and the rise of chronic diseases are driving the demand for over-the-counter (OTC) pharmaceutical products in the region. Additionally, local special circumstances and underlying macroeconomic factors are also contributing to the growth of the market.Customer preferences in Northern Africa are shifting towards self-medication, as consumers seek convenience and cost-effectiveness. The availability of OTC pharmaceutical products allows individuals to treat common ailments without the need for a prescription or a visit to a healthcare professional. This trend is particularly prevalent in urban areas where access to healthcare services may be limited or expensive. Furthermore, the increasing healthcare awareness among the population has led to a greater understanding of minor health issues and the availability of OTC products to address them.Trends in the OTC Pharmaceuticals market in Northern Africa also reflect the rising prevalence of chronic diseases in the region. Conditions such as diabetes, hypertension, and respiratory diseases are becoming more common, leading to a greater demand for OTC medications to manage these conditions. The convenience and accessibility of OTC products make them an attractive option for individuals with chronic diseases who require ongoing medication.Local special circumstances in Northern Africa, such as the high cost of healthcare and limited access to healthcare services in rural areas, are driving the growth of the OTC Pharmaceuticals market. The affordability of OTC products compared to prescription medications makes them a more viable option for many individuals. Additionally, the lack of healthcare infrastructure in rural areas makes it difficult for people to access prescription medications, making OTC products a more accessible alternative.Underlying macroeconomic factors, such as population growth and urbanization, are also contributing to the development of the OTC Pharmaceuticals market in Northern Africa. The region's population is growing rapidly, leading to an increased demand for healthcare products and services. Urbanization is also driving the demand for OTC products, as urban areas tend to have higher levels of disposable income and better access to healthcare facilities.In conclusion, the OTC Pharmaceuticals market in Northern Africa is experiencing growth and development due to customer preferences for self-medication, increasing healthcare awareness, and the rise of chronic diseases. Local special circumstances, such as the high cost of healthcare and limited access to healthcare services, along with underlying macroeconomic factors like population growth and urbanization, are also contributing to the market's expansion.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.